LIFE WITH MYELOMA
Patient Power: Tips for Coping As A New Myeloma Patient
Feb 19, 2019
Patient Power hosted a recent interview with a panel of multiple myeloma patients to discuss valuable advice to help others navigate their journey with cancer. The 7 myeloma patients offered many tips...
ADVERTISEMENT
CLINICAL TRIALS
Clinical Trial: Overall Survival Lengthened for Relapsed/Refractory Myeloma Patients Using CLR 13...
Feb 02, 2019
Myeloma patients who had relapsed after receiving both a proteasome inhibitor (like Velcade) and immunomodulator (like Revlimid)...
SIGN UP FOR OUR
NEWSLETTER
NEWSLETTER
Get the latest thought leadership on multiple myeloma delivered straight to your inbox.
Feb 11, 2019
ADVERTISEMENT
MYELOMA CROWD RADIO
Full Show: A New CD38 Monocloncal Antibody Called Isatuximab Gets Closer to the Clinic, with Ravi Vij, MD, Washington...
Feb 19, 2019
Ravi Vij, MD Washington University Interview Date: February 6, 2019 Summary A new CD38 targeted...
MYELOMA CROWD RESEARCH INITIATIVE
BRINGING THE RIGHT TREATMENT TO THE PATIENT AT THE RIGHT TIME
Please Help Us Reach Our Goal
MYELOMA 101
What Is Relapsed vs. Refractory Myeloma?
Feb 02, 2019
There are so many myeloma phrases, terminology and acronyms that things can get incredibly confusing. Let’s talk about Relapsed Myeloma (sort of self...
MUSCLES FOR MYELOMA
Muscles for Myeloma Columbus 5K and 1 Mile Walk 2019 – June 1 at Wolfe Park
Feb 12, 2019
We are delighted to host the 3rd annual Muscles for Myeloma 5K and 1 Mile Walk, Columbus, Ohio, honoring the Move MMORE Legacy, at Wolfe Park. About Muscles for Myeloma We’re building Muscles for Myeloma to help myeloma patients get moving and to...
CLINICAL TRIALS
Clinical Trial: GVAX Vaccine with Revlimid To Extend Remission
Jan 23, 2019
A new GVAX vaccine is being used in a clinical trial for myeloma patients who have achieved good responses to therapy. The goal of the trial is to extend remissions and potentially deepen responses to a minimal residual disease (MRD)...
FIND
FINANCIAL
RESOURCES
RESOURCES
Find financial resources like housing, prescription and patient assistance programs and other helpful links that will guide you through your myeloma care.
MYELOMA
SPECIALISTS
SPECIALISTS
Patients who are seen by myeloma specialists live longer. Find a myeloma specialists closest to you and add them to your care team for your best outcomes.
CLINICAL
TRIALS
TRIALS
Today's myeloma therapies are yesterday's clinical trials and if more patients joined, we could accelerate a cure.Find a trial that's right for you using a myeloma clinical trial finder called SparkCures.
MYELOMA CROWD RESEARCH INITIATIVE
The Myeloma Crowd Research Initiative (MCRI) is a new approach to funding cancer research; combining the skill and knowledge of leading myeloma specialists with the patient perspective and supportive patient social communities to select and fund promising research projects in myeloma. The goal of the MCRI is to find and fund a cure for multiple myeloma.
Learn More >Thanks to our site sponsors:
